One Death, 125 New Cases, 129 COVID-19 Recoveries Reported in Comal County Wednesday
Comal County today confirmed the COVID-19 death of a New Braunfels woman in her 70s who passed away at home on Sept. 10.
In a statement, the county also reported 125 new cases of the virus and 129 recoveries.
Ninety-four of the new COVID-19 cases are confirmed and 31 are probable.
There are now 1,628 active, confirmed-and-probable cases in the county. Of those, 27 are hospitalized.
The seven-day molecular positivity rate is 14.45%, and the seven-day antigen positivity rate is 10.18%. The TSA P percentage is 16.95%.
Hospitalizations continue to fall. County hospitals are caring for 45 COVID-19 patients. Twelve are in intensive care and six are on ventilators.
Approximately 95% of these patients are unvaccinated.
Not all patients in Comal County hospitals are necessarily county residents. Not all county residents hospitalized with COVID-19 are in Comal County hospitals.
Location Breakdown of New Cases
- New Braunfels – 77
- North of Canyon Lake – 11
- South of Canyon Lake – 10
- South Comal County (Garden Ridge) – 3
- Bulverde/Spring Branch – 24
- Fair Oaks – 0
Age Range of New Cases
- Under 20 – 42
- 20’s – 19
- 30’s/40’s – 37
- 50’s/60’s – 24
- 70 and older – 3
As of Wednesday morning, Public Health reports
- 161,795 tests conducted
- 9,949 confirmed cases
- 7,431 probable cases
- 24 suspect cases
Location Breakdown of All Cases
Of the 17,404 confirmed-and-probable COVID-19 cases in Comal County, the location breakdown is:
- New Braunfels (includes Eastern and Central Comal) – 11,785
- Western Comal County (includes Bulverde and Spring Branch) – 2,780
- South of Canyon Lake – 1,184
- North of Canyon Lake – 995
- Southern Comal County (includes Garden Ridge and Schertz) – 580
- Fair Oaks Ranch – 80
Comal County’s Public Health Department is now administering Moderna COVID-19 vaccines to those 18 years and older and Pfizer vaccines for anyone 12 years and older.
This includes a third dose of either vaccine for anyone who is moderately to severely immunocompromised.
“COVID numbers are at an all-time high and getting vaccinated is still our best shield against the virus,” Public Health Director Cheryl Fraser said in a statement Aug. 30. “We encourage those who have not received the vaccine to consider it. Individuals who are immunocompromised and qualify for the third dose are now eligible to receive it. The hospitals are finding that most of the COVID patients are unvaccinated and very ill.”
People who meet the following criteria are now eligible for a third dose of Moderna or Pfizer mRNA COVID-19 vaccine at least four weeks after a second dose:
- Been receiving active cancer treatment for tumors or cancers of the blood.
- Received an organ transplant and are taking medicine to suppress the immune system.
- Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system.
- Moderate or severe primary immunodeficiency (such as DiGeorge or Wiskott-Aldrich syndromes).
- Advanced or untreated HIV infection.
- Active treatment with high-dose corticosteroids or other drugs that may suppress the immune system.
Those who received either a Pfizer-BioNTech or Moderna’s COVID-19 vaccine series should receive a third dose of the same mRNA vaccine. No additional doses of Johnson & Johnson vaccine are currently recommended.
For more information about COVID-19 vaccines for moderately to severely immunocompromised people, visit the Centers for Disease Control and Prevention website.
“Probable case” is a category established by the Texas Department of State Health Services to describe those who do not have a positive PCR test for COVID-19 but meet two of the three criteria:
- Meets clinical criteria and epidemiologic linkage with no confirmatory laboratory testing performed for SARS-CoV-2.
- Meets presumptive laboratory evidence, which is the detection of SARS-CoV-2 by antigen test in a respiratory specimen.
- Meets vital records criteria with no confirmatory laboratory evidence for SARS-CoV-2.
A probable case is treated identically to a confirmed case and counts toward the county’s positivity rate and total case tally.
A ‘suspect’ case meets supportive laboratory evidence with no prior history of being a confirmed or probable case. It is also counted toward the total case tally. Supportive laboratory evidence means:
- Detection of a specific antibody in serum, plasma, or whole blood.
- Detection of specific antigen by immunocytochemistry in an autopsy specimen.